Navigation Links
Delcath Systems, Inc. Hosts Symposium on Chemosaturation at the SOBRICE Annual Meeting in Brazil
Date:8/15/2011

harmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metas
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Delcath Systems Announces the Sale of 5,185,000 Shares of Common Stock
2. Delcath Highlights Phase III Trial Results Presented at ASCO
3. Delcath Systems Names Michael D. Dellario as Vice President, Global Marketing
4. Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
5. Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index
6. Delcath Enters Agreement to Sell 869,565 Units
7. Delcath Systems Granted Third Orphan Drug Designation
8. Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
9. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
10. Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
11. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 Earlier this year ... L. Sherley, director of the Adult Stem Cell Technology ... often overlooked and under appreciated unique property of adult ... Distributed Stem Cells: Misunderstood in the Past, Important for ... congress participants. He gave the address at the ...
(Date:12/24/2014)... 23, 2014 According to Ross Selinger, President ... of ITRA Global, the national office market continues to be ... This is evidenced by the third quarter’s surprising 3.9% GDP, ... Low energy costs have held inflation down and the Fed ... the housing market remaining soft. , This solid economic news ...
(Date:12/24/2014)... report expects global cell isolation and expansion market to ... carefully analyzed data about the vital drivers, restraints, trends, ... Copy of Report @ http://bit.ly/1yUxy0T , According ... will keep witnessing growth at an impressive CAGR during ... by rapid technological advancements, government funding and investments, and ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... 21 Codexis, Inc., a private,biotechnology company, today announced ... of Vice President and Managing Director of,Codexis Laboratories Singapore ... Dr. Daussmann will report to Alan Shaw, Ph.D., President,and ... Daussmann to this important new,position on the Codexis senior ...
... AMDL, Inc. (Amex:,ADL) announced today that for the ... revenues of $2,413,501, an approximate increase of 69%,over the ... of $1,151,452,and incurred a net loss of ($2,264,305). Included ... depreciation, common stock,warrants and options issued. Gary Dreher, ...
... 10th Anniversary as Public Company, CINCINNATI, Aug. 20 ... clinical research organization, today,announced Chairman and CEO Candace Kendle, ... Market on Aug. 22, 2007, the company,s 10th,anniversary as ... at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) ...
Cached Biology Technology:Codexis Appoints Singapore Laboratories Managing Director 2AMDL Announces 2nd Quarter 2007 Operational Results 2Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22 2
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday ... biometrics industry as Acuity Market Intelligence reports that ... finally be open. Acuity forecasts that intensifying demand ... that incorporate biometrics will drive a global market ... biometric devices by 2020.   According ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research ... announced the addition of the "Samsung Galaxy ... Analysis" report to their offering. ... on a totally different sensing technology than the ... a fingerprint sensor in its product. ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally ... more evident than at international borders. Over the ... scanners have allowed veteran travelers to self process ... Control (APC) Kiosks at an increasing number of ... According to Maxine Most ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... past summer saw a revolution in melanoma therapy. Patients ... gene were successfully treated with a BRAF-specific inhibitor, PLX4032. ... improved health. Yet seven months after therapy began the ... Wistar Institute explain why: the tumor learns to signal ...
... ecology, and development patterns of major northeastern cities combine ... who presented new research today at an American Geophysical ... land surface temperatures of cities in the Northeast were ... warmer than surrounding rural areas over a three year ...
... If current climate projections hold true, the forests of the ... and more frequent forest fires, higher tree death ... university and government scientists are published in this week,s issue ... "Our study shows that regardless of rainfall going up ...
Cached Biology News:Killing drug-resistant melanoma requires combination therapy 2Killing drug-resistant melanoma requires combination therapy 3Satellites pinpoint drivers of urban heat islands in the northeast 2Team of scientists predicts continued death of forests in southwestern US due to climate change 2Team of scientists predicts continued death of forests in southwestern US due to climate change 3
... Virgin, optically clear polystyrene with frosted ... coordinates for cell counting. 100% integrity ... a new product number, created to ... showing no availability yet, please order ...
A cost-effective serum for general cell growth requirements. All serum is collected from calves aged 10 days old or less....
Collected from calves that are 10 days old or less. Sterile, cell culture tested, US Origin...
The LIC Duet™ Mini Adaptor encodes a T7 promoter, lac operator, ribosome binding site (rbs), and an ATG translation initation codon. This adaptor is designed for expression of a target protei...
Biology Products: